ClinConnect ClinConnect Logo
Search / Trial NCT05966623

Assessing the Impact of Vidéo Remote Sign Language Interpreting in Healthcare

Launched by UNIVERSITY OF GENEVA, SWITZERLAND · Jul 25, 2023

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Background and Rationale:

In-person or VRI sign language interpretation is largely unavailable. In a scoping review, the researchers identified a knowledge gap regarding the quality of interpretation and training in sign language interpretation for health care. The researchers also found that this area is under-researched, and the evidence is scant. All available evidence came from high-income countries, which is particularly problematic given that most DHH persons live in low- and middle-income countries. Thus, the available literature shows that VRI may enable deaf users to overcome inte...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Uses Colombian Sign Language as the preferred language.
  • Enough sensorimotor, cognitive and communication skills to communicate independently with health personnel
  • Exclusion Criteria:
  • Does not communicate using sign language.
  • Additional impairments which affect language development or the use of sign language.
  • Refusal of the participant's representative(s) to participate in the study,
  • Refusal of the participant's representative(s) to participate in a modality of the study,

About University Of Geneva, Switzerland

The University of Geneva, located in Switzerland, is a prestigious research institution renowned for its commitment to advancing scientific knowledge and improving public health. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at exploring innovative therapies and enhancing patient care. Its dedicated research teams, equipped with state-of-the-art facilities and a robust ethical framework, strive to translate scientific discoveries into practical applications, ultimately contributing to the global advancement of medical science and the well-being of diverse populations.

Locations

Bogota, , Colombia

Bogotá, , Colombia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported